Hologic wins FDA approval for its new C-View 2D imaging software for use with its 3D breast tomosynthesis mammography system, saying the new software will help reduce exposure to radiation.
Hologic (NSDQ:HOLX) won pre-market approval from the FDA for mammography software it says will help reduce patients' exposure to radiation.
The Bedford, Mass.-based women's health company said its C-View 2D imaging software is meant to replace conventional 2D exposure, a component of Hologic's 3D 3D breast tomosynthesis mammography system.
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-2 preferred stock.
ViewRay Inc. has $2.4 million to go to reach its goal for a $17.4 million funding round
Seven investors are in on the offering, and $15 million had been sold at the time the company disclosed the funding round May 8, according to a regulatory filing.
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint replacements and implanted devices.
GE Healthcare (NYSE:GE) introduced Mavric SL, a novel magnetic resonance imaging technique intended to more accurately image soft tissue and bone in patients with joint replacements and other implants.
Analogic says it's eliminating 140 jobs as it integrates Ultrasonix Medical into its medical device business.
Analogic (NSDQ:ALOG) said it plans to lay off 140 workers worldwide as it integrates Canadian medical device company Ultrasonix Medical and shutters plants in Colorado and Vancouver.
Fiscal 2nd-quarter sales for Siemens Healthcare rose 5% despite a nearly 3% sales decline.
Siemens (NYSE:SI) saw profits rise for its healthcare division even as Siemens Healthcare's sales declined by 2.5% during the German conglomerate's fiscal 2nd quarter.
Sanovas' new MicroCam plug-and-play endoscopic imaging system paves the way for a paradigm shift toward linear medical devices for natural orifice surgery, CEO Larry Gerrans tells MassDevice.com.
In talking about his company's newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
The FDA grants NinePoint Medical an expanded indication for its NvisionLVE system for esophageal imaging.
NinePoint Medical won an expanded FDA nod for its NvisionLVE system, which can now be used for esophageal imaging procedures.
The Cambridge, Mass.-based medical device company won FDA clearance in January 2012 for an indication to evaluate human tissue microstructure.